VCEL(Vericel Corporation) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $156.18M | $164.37M | $197.52M | $237.22M | $276.26M |
| 毛利润 | $106.03M | $109.79M | $135.58M | $172.11M | $205.60M |
| 营业利润 | −$7.85M | −$17.06M | −$6.46M | $4.52M | $11.04M |
| 净利润 | −$7.47M | −$16.71M | −$3.18M | $10.36M | $16.52M |
| 经营现金流 | $29.04M | $17.69M | $35.31M | $58.16M | $51.91M |
| 自由现金流 | $21.12M | $10.09M | $15.30M | −$5.81M | $24.75M |
| 摊薄每股收益 | $-0.16 | $-0.35 | $-0.07 | $0.20 | $0.32 |